Solange Valdes Selected Research

Docosahexaenoyl difluorodeoxycytidine

1/2017	Preclinical Evaluation of the Short-Term Toxicity of 4-(N)-Docosahexaenoyl 2´, 2´- Difluorodeoxycytidine (DHA-dFdC).
1/2016	Synthesis, Characterization, and In Vitro and In Vivo Evaluations of 4-(N)-Docosahexaenoyl 2', 2'-Difluorodeoxycytidine with Potent and Broad-Spectrum Antitumor Activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Solange Valdes Research Topics

Disease

2	Leukemia 01/2017 - 01/2016
2	Neoplasms (Cancer) 01/2016 - 01/2016
1	Leukemia L1210 01/2017
1	Adenocarcinoma 01/2016
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2016
1	Triple Negative Breast Neoplasms 01/2016

Drug/Important Bio-Agent (IBA)

2	Docosahexaenoyl difluorodeoxycytidineIBA 01/2017 - 01/2016
1	Mannose (D-Mannose)IBA 01/2016
1	Zoledronic Acid (Zometa)FDA Link 01/2016

Therapy/Procedure

1	Intravenous Injections 01/2016
1	Therapeutics 01/2016